Skip to the page

Data / Form D filings / Gong Sheng Yuan Biotechnology Corp

Gong Sheng Yuan Biotechnology Corp: Form D filing

Gong Sheng Yuan Biotechnology Corp, a biotechnology company in Hangzhou, China, filed a Form D with the SEC in 2023. The latest, on December 14, 2023, reports an offering of $10 million with nothing sold yet to 200 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
626 SCIENCE MUSEUM STREET, Hangzhou, China, 31005
Phone
0086-0571-87761662
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Cayman Islands
Year incorporated
2023
Revenue range
$5,000,001 - $25,000,000
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
2004372

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Dec 14, 2023New notice$10,000,000$0$10,000,000200Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Changchun TangDirector

Every Form D from the week of Dec 11, 2023 · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Gong Sheng Yuan Biotechnology Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.